Local med tech company raises cash for commercialisation
The wrong IV drugs kill and maim more than 500 New Zealanders each year. A start-up founded by TIN100 principal Greg Shanahan is trying to help. With special feature audio.
Calida Smylie Tue, 19 Apr 2016
Devonport-based medical technology company Veriphi is raising up to $2 million on equity crowdfunding platform Snowball Effect, as it moves toward commercialisation of its patient safety product.
The start-up has developed laser technology, which it hopes will prevent numerous New Zealanders dying
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).